Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Jul 15, 2021; 13(7): 638-661
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.638
Published online Jul 15, 2021. doi: 10.4251/wjgo.v13.i7.638
Diagnostic biomarker | Molecular level | Sample | Expression | Ref. |
Actin Beta-Like 2 | Protein | Fresh frozen tissue | ↑ | Ghazanfar et al[30], 2017 |
Dipeptidase 1 | Protein | Fresh frozen tissue | ↑ | Hao et al[31], 2017 |
Olfamectomedin-4 | Protein | FFPE tissue | ↑ | Quesada-Calvo et al[32], 2017 |
Kininogen-1 | ||||
Transport Protein Sec-24 | ||||
Cyclophilin A | Protein | FFPE tissue | ↑ | Yamamoto et al[33], 2016 |
Annexin A2 | ||||
Aldolase A | ||||
Leucine-Rich Alpha-2 Glycoprotein 1 | Protein | Serum | ↑ | Ivancic et al[36], 2020 |
Epidermal Growth Factor Receptor | ||||
Hemopexin | ||||
Superoxide Dismutase 3 | ||||
Inter-Alpha-Trypsin Inhibitor Heavy-Chain Family Member 4 | ||||
Mannan Binding Lectin Serine Protease 1 | Protein | Plasma | - | Bhardwaj et al[37], 2019 |
Osteopontin | ||||
Serum Paraoxonase Lactonase 3 | ||||
Transferrin Receptor Protein 1 | ||||
Amphiregulin | ||||
Adipophilin | Protein | Plasma | - | Matsubara et al[41], 2011 |
Caldesmon 1 | Protein | Fresh Frozen Tissue | - | Ilyas et al[34], 2020 |
Catenin Beta 1 | ||||
C-X-C Motif Chemokine Ligand 14 | ||||
Protein patched homolog 1 | ||||
Interleukin-8, Tumor necrosis factor-alpha induced protein 3, Nicotinamide N-methyltransferase | ||||
Mitogen-activated protein kinase | ||||
Adenomatous polyposis coli | ||||
Zinc finger protein | ||||
Serine/Threonine Kinase 4 | Protein | Serum | ↓ | Yu et al[38], 2017 |
Macrophage mannose receptor 1 | Protein | ↑ | Fan et al[39], 2016 | |
S100 calcium binding protein | ||||
Alpha-1-antitrypsin | Protein | Serum | ↑ | Peltier et al[40], 2016 |
Alpha-1-antichymotrypsin | ||||
Anti- Thombin 3 | Protein | Serum | ↓ | Peltier et al[40], 2016 |
3- Hydroxybutyric Acid | Serum | ↑ | Ma et al[43], 2012 | |
Microtubule Actin Crosslinking Factor 1 | Protein | Serum | ↑ | Ma et al[43], 2012 |
L-Valine | Amino acid | Serum | ↓ | Ma et al[43], 2012 |
L-Threonine | ||||
1-Deoxyglucose | ||||
Glycine | ||||
Apolipoprotein H | Protein | Serum | ↓ | Ma et al[43], 2012 |
Alpha-2-Macroglobulin | ||||
Immunoglobulin Lambda Locus | ||||
Vitamin-D-binding protein | ||||
Acetoacetate, Guanidinoacetate | Amino acid | Urine | ↑/High | Wang et al[48], 2017 |
Cis-aconitate, Trans-aconitate, Glutamine | ||||
Homocysteine | ||||
Creatinine, Phosphorylcholine | Amino acid | Urine | ↓/Low | Wang et al[48], 2017 |
Dimethyl sulfone, Asparagine, Alanine | ||||
Isocitrate, Hippurate, Methylamine | ||||
Cysteine, Phenylalanine | ||||
Isoleucine, β-Hydroxybutyrate, lactate, acetate, glutamate, choline, glycine, serine, glucose | Amino acid | Biopsy | High | Nishiumi et al[46], 2012 |
Taurine, alanine, β –Aminoisobutyrate, valine | Amino acid | Urine | High | Kim et al[47], 2019 |
Threonine, glycerol, hippurate, ascorbate, creatinine and citrate | Amino acid | Urine | Less | Kim et al[47], 2019 |
Proline, succinate, isoleucine, leucine valine, alanine, glutamate, dimethylglycine and lactate | Amino acid | Fecal | High | Lin et al[44], 2019 |
Short Chain Fatty Acids, (acetate, propionate and butyrate), glucose, glutamine | Amino acid | Fecal | Less | Lin et al[44], 2019 |
Sphinganine, endocannabinoids | Serum | High | Martín-Blázquez et al[51], 2019 | |
CRCAL-4, CRCAL-3, CRCAL-2 (Long Intergenic Non-Protein Coding RNA 858), and CRCAL-1 | lncRNA | CRC cell line | ↑ | Yamada et al[27], 2018 |
NONHSAT074176.2 | lncRNA | Fresh frozen tissue | ↓ | Zhang et al[28], 2018 |
CircDDX17 | lncRNA | Fresh frozen tissue | Dysregylated | Li et al[29], 2018 |
Syndecan 2 | Gene | Fresh frozen tissue | ↑ | Oh et al[20], 2013 |
PHOX1B, Glutamic acid de-carboxylase 2, and Fibroblast Growth Factor 12 | Gene | Fresh frozen tissue | ↑ | Li et al[21], 2012 |
Visual System Homeobox 2 | Gene | Neoplastic colonic tissue | ↑ | Mori et al[22], 2011 |
Prognostic biomarker | Molecular level | Sample | Expression | Ref. |
Carcinoembryonic antigen | Protein | Plasma | ↑ | Li et al[79], 2018 |
Major histocompatibility complex, class I, B (HLAB) | Protein | Fresh Frozen Tissue | ↑ | Kirana et al[80], 2019 |
14-3-3b protein (YWHAB) | ||||
A disintegrin and metalloproteinase with thrombospondin motifs 2 | ||||
Leukotriene B3 | ||||
Nucleoside Diphosphate Kinase 2 | ||||
Jagged Canonical Notch Ligand 2 | ||||
Collagen type XII (FACIT) | Protein | Colorectal liver metastasis tissue | ↑ | van Huizen et al[81], 2019 |
Heat shock protein 47 | Protein | Fresh Frozen Tissue | ↑ | Mori et al[82], 2017 |
Ezrin protein | Protein | Cells and tissue | ↑ | Patara et al[85], 2011 |
Collagen VI (COL6) | Protein | Fresh Frozen Tissue | ↑ | Clarke et al[86], 2017 |
Forkhead box O3 | ||||
RAD51 (DNA repair protein RAD51 homolog 1) | ||||
Lymphocyte-specific protein tyrosine kinase | ||||
Inositol polyphosphate-4-phosphatase | ||||
Phospho-PEA15 (Ser116) | ||||
Phosho-S6 (Ser240-244) | ||||
Phospho-PRAS40 (Thr-246) | ||||
Mammary serine protease inhibitor | Protein | Fresh Frozen Tissue | ↑ | Snoeren et al[87], 2013 |
Alpha-fetoprotein | Protein | Serum | - | Zhu et al[88], 2013 |
Complement C4-A (C4A) | ||||
Fibrinogen alpha | ||||
Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (GSPT2) | ||||
Angiotensinogen | ||||
Hippurate, Butyrate | Amino acid | Urine | ↑ | Liesenfeld et al[89], 2015 |
Glycerol, Galactarate | ||||
Urea, Carnitine | Amino acid | Urine | ↓ | Liesenfeld et al[89], 2015 |
AFAP1 Antisense RNA 1 | lncRNA | Datasets | ↑ | Li et al[72], 2016 |
Breast Cancer Anti-Estrogen Resistance 4 | ||||
H19 | ||||
HOXA Cluster Antisense RNA 2 | ||||
Metastasis Associated | ||||
Lung Adenocarcinoma Transcript 1 (MALAT1) | ||||
Plasmacytoma Variant Translocation 1 | ||||
ADAMTS9 Antisense RNA 2 | lncRNA | Datasets | ↓ | Li et al[72], 2016 |
miR-429 | microRNA | Fresh Frozen Tissue | ↓ | Li et al[73], 2013 |
hsa-mir-191, hsa-mir-200b | microRNA | Datasets | - | Kandimalla et al[75], 2018 |
hsa-mir-30b, hsa-mir-30c2 | ||||
hsa-mir-33a, hsamir-362 | ||||
hsa-mir 429, and hsa-mir-744 | ||||
VNN1-AB | Transcript | Datasets | - | Løvf et al[76], 2014 |
Kirsten rat sarcoma oncogene 2 (KRAS) | Gene | Datasets | - | Kadowaki et al[67], 2015 |
Murine sarcoma viral oncogene homolog B1 (BRAF) | ||||
Tumor protein 53 | Gene | Datasets | - | Ting et al[59], 2013 |
SMAD Family Member 4 | Gene | Datasets | - | Mei et al[65], 2018 |
Neurofibromatosis type 1 |
Drug (s) | Pharmacological class | Original indication | CRC effect | Ref. |
Based on computational approaches | ||||
GW-8510, ethacrynic acid, ginkgolide A and 6-azathymine | GW-8510: Inhibitor of cyclin-dependent kinase-2; ethacrynic acid: Diuretic; ginkgolide A: Platelet-activating factor antagonist; 6-azathymine: D-3-aminoisobutyrate-pyruvate aminotransferase inhibitor | GW-8510: Prevention of chemotherapy-induced alopecia; ethacrynic acid: Treatment of high blood pressure and swelling; ginkgolide A: Treatment of a wide variety of cognitive and vascular disorders | Inhibit CRC cells | Chung et al[97], 2014 |
6-azathymine: Has antibacterial and antiviral activities | ||||
GW-8510 | Inhibitor of cyclin-dependent kinase-2 | Prevention of chemotherapy-induced alopecia | CRC therapeutic agent which targets RRM2 inhibition | Hsieh et al[98], 2016 |
Abemaciclib | Anti-neoplastic | Treatment of advanced or metastatic breast cancers | CRC therapeutic agent which targets FABP6 | Liñares-Blanco et al[99], 2020 |
AG 957, Ro-28-1675, Brazilin, Importazole, PD 407824 | AG 957: Inhibitor; Ro-28-1675: Activator; Brazilin: Anti-inflammatory agent; Importazole: Inhibitor; PD 407824: Indoles and derivatives | AG 957: Protein tyrosine kinase; Ro-28-1675: Glucokinase activator; Brazilin: NF-kappaB inhibitor and a hepatoprotective agent; Importazole: Transport receptor importin-β; PD 407824: Wee1/Chk1 inhibitor | CRC drug candidates | Beklen et al[100], 2020 |
Based on clinically or experimentally validated approaches | ||||
Metformin | Antidiabetic agent | Treatment of type 2 diabetes mellitus | Reduces pre-cancerous lesions and cancerous cell proliferation | Jia et al[102], 2015 |
Results in better overall survival | Bishnoi et al[104], 2018 | |||
Causes both apoptosis and autophagy of cultured HT29 cells | Sena et al[103], 2018 | |||
Aspirin | Nonsteroidal anti-inflammatory | Relieves minor aches, pains, and fevers | Regular, long-term aspirin use reduces CRC risk | Chan et al[105], 2005 |
Reduces CRC cell proliferation | Reddy et al[106], 2006 | |||
Daily use for about 5 yr is efficient in prevention, with a latency time of about 10 yr | Flossmann et al[107], 2007 | |||
Restrains CRC tumor metastasis | Jin et al[108], 2019 | |||
Cimetidine | Gastrointestinal agent | Treatment of ulcers and gastroesophageal reflux disease | Short course of cimetidine treatment has an impact on patient survival | Kelly et al[110], 1999 |
Inhibits the adhesion of CRC cells and represses spread of cancer cells | Kobayashi et al[111], 2000 | |||
Reduces frequency of metastasis and increases survival rate | Matsumoto et al[112], 2002 | |||
Prolongs the probability of recurrence | Ali et al[113], 2018 | |||
Diclofenac | Nonsteroidal anti-inflammatory | Relieves pain and inflammation | Contributes to tumor growth inhibition in colon cancer | Falkowski et al[116], 2003 |
Promotes cell death | Arisan et al[117], 2018 | |||
Chloroquine | Antimalarial | Treatment of malaria | Increases cell inhibition and decreases reproduction | Sasaki et al[119], 2010 |
Use at high doses (40–160 μM) encourages lysosomal membrane permeabilization and cell death | Park et al[120], 2014 | |||
Sulindac | Nonsteroidal anti-inflammatory | Reduces pain, swelling, and joint stiffness due to arthritis | Decreases final tumor counts and prevents CRC especially when given in intermittent doses | Chandra et al[122], 2017 |
Decreases polyp count | Davis et al[123], 2020 | |||
Mesalazine | Anti-inflammatory | Treatment of mild to moderate ulcerative colitis | Decreases CRC cell number and enhances apoptosis | Reinacher-Schick et al[125], 2003 |
Causes CRC cell cycle arrest and cell death | Koelink et al[126], 2010 | |||
Disulfiram | Enzyme inhibitor | Alcohol addictive disorder | Promotes cell viability inhibition | Stenvang et al[128], 2018 |
Erlotinib | Anti-neoplastic | Treatment of non-small cell lung and pancreatic cancer | Contributes to enhanced progression-free survival and overall survival of metastatic CRC patients | Shi et al[130], 2017 |
- Citation: Beklen H, Yildirim E, Kori M, Turanli B, Arga KY. Systems-level biomarkers identification and drug repositioning in colorectal cancer. World J Gastrointest Oncol 2021; 13(7): 638-661
- URL: https://www.wjgnet.com/1948-5204/full/v13/i7/638.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i7.638